Yu Jung Kim

Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance

Hyesil Seol, Hyun Ju Lee, Yoomi Choi et al. · Modern Pathology · 2012 · 327 citations · Full text

Intratumoral Heterogeneity, Breast Oncology, Pathology +8

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer

Heae Surng Park, Min Hye Jang, Eun Joo Kim et al. · Modern Pathology · 2014 · 283 citations · Full text

Breast Oncology, Poor Outcome, Medicine +9

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

Sehhoon Park, Chan‐Young Ock, Hyojin Kim et al. · Journal of Clinical Oncology · 2022 · 262 citations · Full text

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer

Jin Won Kim, Kyung Han Nam, Sang-Hoon Ahn et al. · Gastric Cancer · 2014 · 248 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +11

Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

Jun Yeun Cho, Junghoon Kim, Jong Seok Lee et al. · Lung Cancer · 2018 · 199 citations

Cancer Immunosurveillance, Medicine, Immunology +9